Neoadjuvant PD-1 blockade in dMMR tumors "could potentially eradicate the need for chemotherapy, radiation, and surgery in ...

Trial Platform (PTP), led by Drs. Adam Boxer (University of California, San Francisco [UCSF]), Irene Litvan (University of California, San Diego), Julio Rojas (UCSF) and ...

NITAAC Director Ricky Clark said the organization’s website should be back up in another day or two, while industry rises to defense NASA SEWP’s future.

The FDA expect to revoke authorization for Citrus Red No. 2 and Orange B in the next several months, followed by 6 additional dyes by the end of 2026. HealthDay News — The U.S. Department of Health ...